Analyst Price Targets — ENOV
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 1, 2026 6:57 pm | — | BTIG | $36.00 | $20.53 | TheFly | Enovis price target lowered to $36 from $40 at BTIG |
| September 1, 2026 5:52 pm | — | BMO Capital | $27.00 | $21.67 | TheFly | Enovis price target lowered to $27 from $30 at BMO Capital |
| August 17, 2026 11:07 am | — | Canaccord Genuity | $45.00 | $26.06 | TheFly | Enovis price target lowered to $45 from $50 at Canaccord |
| August 7, 2026 11:41 am | Vik Chopra | BMO Capital | $30.00 | $26.31 | TheFly | Enovis price target raised to $30 from $29 at BMO Capital |
| July 28, 2026 10:30 am | — | UBS | $51.00 | $28.25 | TheFly | Enovis assumed with a Buy at UBS |
| July 8, 2026 8:15 pm | — | BMO Capital | $29.00 | $23.63 | TheFly | Enovis initiated with an Outperform at BMO Capital |
| July 6, 2026 12:42 pm | — | Evercore ISI | $32.00 | $24.39 | TheFly | Enovis price target lowered to $32 from $36 at Evercore ISI |
| May 8, 2026 12:00 pm | — | Evercore ISI | $36.00 | $27.28 | TheFly | Enovis price target raised to $36 from $35 at Evercore ISI |
| February 26, 2026 8:48 pm | Mike Matson | Needham | $52.00 | $25.42 | StreetInsider | Enovis Corp (ENOV) PT Raised to $52 at Needham |
| January 6, 2026 11:21 am | Ryan Zimmerman | BTIG | $41.00 | $27.01 | TheFly | Enovis initiated with a Buy at BTIG |
Latest News for ENOV
Enovis Corporation (NYSE: ENOV - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Wednesday. The stock traded as low as $17.30 and last traded at $17.9220, with a volume of 2658431 shares changing hands. The stock had previously closed at $18.22. Analysts Set New Price Targets ENOV has been
Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline.
Enovis (ENOV) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Enovis (ENOV) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
ENOV is set to acquire eCential Robotics to expand into orthopedic surgical robotics, though the deal is expected to pressure 2027 margins.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for ENOV.
U.S. House Trading
No House trades found for ENOV.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.